e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Diagnosis and treatment of drug susceptible and resistant tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Influence of candida species fungi on growth and pathogenicity of mycobacteria tuberculosis
U. Khidoyatov (Almaty, Kazakhstan)
Source:
Annual Congress 2007 - Diagnosis and treatment of drug susceptible and resistant tuberculosis
Session:
Diagnosis and treatment of drug susceptible and resistant tuberculosis
Session type:
Thematic Poster Session
Number:
3864
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
U. Khidoyatov (Almaty, Kazakhstan). Influence of candida species fungi on growth and pathogenicity of mycobacteria tuberculosis. Eur Respir J 2007; 30: Suppl. 51, 3864
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli
Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection
Year: 2020
From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Identification of Mycobacterium tuberculosis (MTB)-infection in immunocompromised hosts
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
Non-tuberculous mycobacteria in the environment and as human pathogens
Source: Annual Congress 2011 - Non-tuberculous mycobacterial infections
Year: 2011
Frequency of candida species mycoses isolation from patients with pulmonary tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 422s
Year: 2004
Characterization of drug susceptibility of nontuberculous mycobacteria of M.chelonae and M.fortuitum complexes.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011
Characterisation of patients with multiple isolates of different species of non-tuberculous mycobacteria: a new phenomenon?
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Express-diagnosing of multidrug resistant bacterial and L-forms of mycobacterium tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 721s
Year: 2004
Causative bacteria in protracted bacterial bronchitis are biofilm forming species
Source: International Congress 2018 – Orphan diseases in children
Year: 2018
Allergy and immunity to fungal infections and colonization
Source: Eur Respir J 2002; 19: 151-157
Year: 2002
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010
Other fungal and protozoan infections
Source: Eur Respir Monogr 2014; 66: 171-185
Year: 2014
Novel approach to species identification of nontuberculous mycobacteria
Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis
Year: 2010
Mycobacterium tilburgii infection in an HIV-seropositive host
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009
In vitro susceptibility of non-tuberculous mycobacterial strains against moxifloxacin
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools
Year: 2012
Evaluating the non-tuberculous mycobacteria effect in the tuberculosis infection diagnosis
Source: Eur Respir J 2010; 35: 338-342
Year: 2010
Estimation of susceptibility hospital strains of Mycobacterium tuberculosis (Mtb) Beijing to disinfectants
Source: International Congress 2017 – Paediatric TB: MDRTB (II)
Year: 2017
Infection or colonisation: indicators to initiate antimycobacterial treatment in nontuberculous mycobacterial infections
Source: Annual Congress 2010 - Advances in the diagnosis of tuberculosis and nontuberculous mycobacterial infections: a joint ERS and ATS symposium
Year: 2010
Influence of glutoxim and its derivatives on the growth of
mycobacterium tuberculosis
(Mtb)
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept